Researchers use optogenetics to produce pain relief by shutting off neurons with light
The potential of light as a non-invasive, highly-focused alternative to pain medication was made more apparent thanks to research conducted by scientists at the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.
Researchers bred mice with a light-sensitive trait in peripheral neurons that were known to be responsible for pain transmission. The mice were genetically modified so that these neurons, called Nav 1.8+ nociceptors, express proteins called opsins, which react to light, a process known as optogenetics.
When these sensory neurons are exposed to yellow light, the opsins move ions across the membrane, reducing the level of bioelectric activity of the cells. This effectively shuts off the neurons, decreasing the mouse’s sensitivity to touch and heat.
“The opsins we added to these neurons were initially isolated from archaebacteria and sense yellow light,” explains Professor Philippe Séguéla, a researcher at the Montreal Neurological Institute and Hospital and the article’s senior author. “When we transfer these to neurons, we can control their responses simply by illuminating the skin with innocuous yellow light.”
Optogenetics is a growing field of research with a wide variety of applications. In this case the activity of pain-signaling neurons was reduced in a localized part of the mouse’s body, the hind paw, and the duration of the effect could easily be controlled by the amount of time the light was applied. The precision of this technique underlines potential advantages for use in humans.
Light therapy based on optogenetics would have the advantage of providing “on-demand” analgesia (pain relief) to patients who could control their pain by shining light on the sensitive part of the body.
Opiates are the most commonly used treatment for chronic pain today, but they are often used systemically and not directed to the specific region of the body affected by the pain. The duration of the opiate effects can be estimated, but without the same precision as a beam of light.
Further advances in neuroscience are necessary to apply this method of pain relief to humans. Séguéla says one possible way to make human neurons photosensitive would be through the use of a harmless virus that could temporarily deliver opsins to certain neurons without causing side effects.
According to a report in the Community Health Survey, 1 in 10 Canadians between the ages of 12 and 44, about 1.5 million in total, experienced chronic pain—pain lasting over a period of months or years. Chronic pain is associated with a number of different medical conditions including diabetes, arthritis, cancer, shingles, and sciatica, among others. Chronic pain reduces the sufferer’s ability to perform daily tasks and may lead to other health issues such as sleep disorders and depression.
“Chronic pain is an increasingly big problem clinically and for many years we’ve relied only on opiates,” says Séguéla. “It’s hard to treat because of tolerance, making it necessary to increase dosages, which leads to serious side effects. Optogenetic therapy could be a highly effective way to relieve chronic pain while avoiding the side effects of traditional pain medication.”
Learn more: Brighter prospects for chronic pain
The Latest on: Chronic pain
via Google News
The Latest on: Chronic pain
- What the pelvic floor can tell health care providers about how to treat chronic pelvic painon June 29, 2022 at 2:05 pm
Among patients with chronic pelvic pain and urinary issues, those with intense soreness throughout their pelvic floors are more likely to experience pain that is driven by the central nervous system.
- Early warning score for chronic pain after surgeryon June 29, 2022 at 7:53 am
A Dutch-German research team examined warning signs for chronification of pain after surgery. The most important risk factors were found to be skeletal surgery, preoperative opioid use, pain lasting ...
- Suffering From Chronic Back Pain? This New Non-Surgical Treatment May Help.on June 28, 2022 at 10:06 am
Dr. Richard Bundschu has performed Intracept a few times at his outpatient facility in Bradenton. The treatment takes 60-90 minutes and recovery takes a few days.
- Easing your chronic back pain — with and without medicationon June 27, 2022 at 11:00 am
Get the full experience.Choose your plan Back pain is considered chronic if it continues for more than 12 weeks. In older adults, chronic low-back pain may be overtreated with inappropriate ...
- Startling new science reveals the truth about chronic painon June 27, 2022 at 10:41 am
Dr. Haider Warraich brings his experiences as a physician and patient to his examination of the nature and history of pain. Condemning modern medicine's failures, he calls for a more holistic, ...
- Living with chronic pain: ‘Fibromyalgia felt like someone was hacking my bones away’on June 24, 2022 at 10:00 pm
'The pain was like I’d sat in a nest of fire ants and they were crawling all over my body and biting me... I would cry myself to sleep most nights' ...
- Heal-n-Soothe Reviews (Updated) – How Does This Chronic Pain Supplement Work?on June 24, 2022 at 3:18 pm
Listen to this article Arthritis is one of the most common yet painful health conditions globally. The majority of us fall victim to arthritis after turning 30. The severity of the pain only worsens ...
- How do painkillers actually kill pain? From ibuprofen to fentanyl, it's about meeting the pain where it's aton June 24, 2022 at 5:02 am
To avoid injury, pain tells us to use a hammer more gently, wait for the soup to cool or put on gloves in a snowball fight. Those with rare inherited disorders that leave them without the ability to ...
- Australian man with chronic pain breaks world record for number of pushups done in 1 houron June 22, 2022 at 4:54 pm
Looks like Australians have the secret recipe when it comes to doing a record-breaking number of pushups in an hour. Daniel Scali of Australia just beat the previous world record for most pushups done ...
- Cannabis for chronic pain? SA’s first clinical trial to beginon June 22, 2022 at 5:01 am
The trial has been dubbed the Pharma Ethics Observational Study. The trial’s aim is to test if cannabis can be a replacement for opioids in the management of chronic pain, says Biodata. Biodata is a ...
via Bing News